02190.HK
Zylox-Tonbridge Medical Technology Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 18.64
−3.02%Year over year
Reported trailing growth
- Revenue
- +34.4%
- EBITDA
- +204.7%
- EBIT
- +573.1%
- EPS
- +103.3%
- Free cash flow
- +230.9%
- Operating cash flow
- +95.1%
Forward estimates
Based on analyst estimates
- Revenue
- -45.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +46.8%
- EBITDA
- +218.9%
- EBIT
- +222.8%
- Net income
- +143.7%
- EPS
- +145.2%
- Free cash flow
- +1656.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026